Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
PLX	PROTALIX BIOTHERAPEUTICS INC	$3.00	-2.28%	2.04%	18.11%	23.97%	140.00%	147.93%	165.49%	-7.41%	-86.24%	$3.10	$0.82	3.23%	265.41%	0.65	538,561	-41.22%
AUPH	AURINIA PHARMACEUTICALS INC	$8.20	-0.49%	1.23%	1.86%	4.99%	12.02%	57.69%	-24.70%	-47.74%	121.02%	$10.67	$4.99	23.15%	64.33%	1.06	888,819	-17.07%
CPRX	CATALYST PHARMACEUTICALS INC	$24.27	-0.08%	4.66%	1.46%	7.29%	10.87%	59.67%	210.76%	427.61%	628.83%	$26.16	$14.47	7.22%	67.73%	1.07	1,060,804	12.60%
NAGE	NIAGEN BIOSCIENCE INC	$7.56	-3.69%	2.44%	10.04%	37.70%	29.01%	106.56%	279.90%	44.00%	115.38%	$9.18	$2.31	17.65%	227.98%	1.23	424,059	2.74%
RIGL	RIGEL PHARMACEUTICALS INC	$18.72	-4.29%	-1.78%	9.15%	-11.53%	31.83%	71.74%	-23.90%	9.47%	-58.49%	$29.82	$7.48	37.22%	150.13%	1.37	151,966	3.40%
BMRN	BIOMARIN PHARMACEUTICAL INC	$62.71	-1.54%	-0.05%	-7.70%	0.43%	-5.84%	-24.74%	-24.73%	-28.84%	-45.90%	$94.85	$52.93	33.89%	18.48%	0.73	1,564,666	20.68%
INCY	INCYTE CORP	$62.03	-1.01%	5.19%	1.84%	-15.88%	-18.52%	17.17%	-18.44%	-36.25%	-36.88%	$83.95	$52.73	26.11%	17.64%	0.57	2,438,897	-13.59%
EXEL	EXELIXIS INC	$38.89	-0.66%	4.51%	6.87%	18.28%	13.98%	77.38%	71.62%	61.37%	1,274.20%	$40.02	$20.14	2.82%	93.10%	0.62	2,455,084	14.14%
JAZZ	JAZZ PHARMACEUTICALS PLC	$117.18	0.19%	7.52%	-6.25%	-3.93%	6.09%	6.23%	-25.51%	6.93%	-35.17%	$148.06	$95.49	20.85%	22.71%	0.71	1,286,249	14.11%
TECH	BIO-TECHNE CORP	$49.63	-1.43%	-2.26%	-13.46%	-31.12%	-34.10%	-32.44%	-48.11%	-12.75%	105.23%	$85.57	$46.01	42.00%	7.87%	1.13	1,609,235	5.18%
CSBR	CHAMPIONS ONCOLOGY INC	$6.38	-10.77%	-16.16%	-25.90%	-36.26%	59.50%	31.28%	-16.38%	-16.60%	-18.21%	$11.99	$3.60	46.79%	77.22%	0.50	70,650	163.22%
CRMD	CORMEDIX INC	$9.65	5.01%	5.46%	58.98%	-2.13%	-3.40%	74.82%	173.37%	160.11%	-74.64%	$13.85	$3.61	30.32%	167.31%	1.08	1,724,328	47.70%
XERS	XERIS BIOPHARMA HOLDINGS INC	$4.48	-1.97%	4.67%	-11.81%	24.79%	38.70%	156.00%	82.11%	83.23%	N/A	$6.07	$1.72	26.19%	160.47%	1.23	1,864,116	-10.82%
GMAB	GENMAB A	$20.93	-1.04%	1.90%	12.17%	9.52%	-7.23%	-27.20%	-39.87%	-16.28%	172.60%	$30.41	$17.24	31.17%	21.44%	0.72	1,263,895	-6.69%
HALO	HALOZYME THERAPEUTICS INC	$60.03	-2.26%	1.32%	-2.97%	6.66%	5.04%	52.75%	46.95%	159.09%	280.18%	$66.00	$39.79	9.05%	50.87%	0.85	1,139,738	-16.57%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$14.65	-1.74%	-0.48%	-2.20%	15.45%	68.97%	65.72%	-31.35%	-43.65%	N/A	$17.75	$6.99	17.46%	109.59%	1.19	1,498,719	17.44%
HRTX	HERON THERAPEUTICS INC	$2.35	-2.89%	3.52%	11.37%	39.05%	32.02%	0.43%	-50.94%	-82.86%	-78.66%	$3.93	$1.04	40.20%	125.96%	1.47	1,437,482	29.50%
ALNY	ALNYLAM PHARMACEUTICALS INC	$255.13	-3.08%	5.16%	-0.25%	-7.07%	-6.86%	70.13%	83.48%	97.82%	138.68%	$304.39	$144.73	16.18%	76.28%	0.89	1,519,735	60.07%
NVO	NOVO NORDISK A S	$65.60	-1.28%	4.74%	-3.57%	-20.63%	-41.40%	-49.23%	15.25%	106.84%	129.53%	$148.15	$57.00	55.72%	15.09%	0.57	16,257,075	75.89%
THTX	THERATECHNOLOGIES INC	$2.92	2.82%	3.55%	108.57%	100.00%	139.34%	124.62%	-70.08%	-69.07%	-26.26%	$3.13	$1.08	6.71%	170.37%	0.77	286,206	-13.24%
PBYI	PUMA BIOTECHNOLOGY INC	$3.08	-3.14%	2.33%	5.12%	10.39%	4.41%	-37.78%	33.33%	-67.51%	-98.36%	$5.26	$2.23	41.44%	38.43%	0.96	228,342	-58.66%
VRTX	VERTEX PHARMACEUTICALS INC	$498.86	-2.09%	1.30%	2.91%	6.06%	5.89%	24.05%	90.43%	95.71%	297.18%	$519.88	$377.85	4.04%	32.03%	0.57	1,440,898	-0.34%
ACAD	ACADIA PHARMACEUTICALS INC	$14.57	-0.21%	-1.75%	-10.72%	-21.29%	-1.62%	-14.55%	-25.44%	-67.57%	-59.15%	$20.68	$13.40	29.55%	8.73%	0.88	1,432,957	-23.09%
UTHR	UNITED THERAPEUTICS CORP	$293.85	-3.05%	-0.87%	-4.25%	-17.13%	-21.43%	15.17%	63.41%	169.29%	71.92%	$417.82	$255.93	29.67%	14.82%	0.49	426,972	-45.60%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$29.86	1.32%	1.46%	-7.90%	-22.84%	-9.73%	-1.35%	-33.79%	N/A	N/A	$41.61	$26.47	28.24%	12.81%	0.85	715,664	64.40%
VRNA	VERONA PHARMA PLC	$72.26	0.26%	11.55%	23.44%	22.52%	106.58%	374.77%	1,752.82%	1,776.88%	N/A	$74.18	$11.39	2.59%	534.42%	0.79	1,607,314	9.34%
FENC	FENNEC PHARMACEUTICALS INC	$6.11	1.16%	7.38%	10.49%	-6.00%	40.78%	-32.78%	-0.65%	-3.32%	155.65%	$10.07	$3.96	39.30%	54.29%	0.67	66,464	0.15%
RPRX	ROYALTY PHARMA PLC	$32.48	-1.04%	1.40%	4.20%	3.67%	19.85%	15.71%	-23.31%	N/A	N/A	$34.20	$24.05	5.03%	35.05%	0.53	2,605,651	-42.68%
INVA	INNOVIVA INC	$18.65	-0.21%	1.47%	3.96%	1.30%	-3.17%	22.46%	14.35%	38.66%	12.15%	$21.28	$15.07	12.36%	23.76%	0.51	522,577	-5.25%
MNKD	MANNKIND CORP	$4.95	-1.79%	6.00%	0.00%	-11.13%	-30.96%	14.06%	50.91%	296.00%	-76.32%	$7.63	$4.17	35.12%	18.85%	1.10	1,480,761	-26.29%
TGTX	TG THERAPEUTICS INC	$45.37	-0.31%	12.58%	20.19%	44.12%	68.66%	185.71%	500.93%	302.93%	217.49%	$46.48	$15.16	2.39%	199.27%	1.87	2,543,840	-22.25%
ARGX	ARGENX SE	$639.90	-0.81%	6.56%	12.84%	-2.69%	7.44%	66.93%	118.14%	339.73%	N/A	$678.21	$352.77	5.65%	81.39%	0.70	176,184	-44.91%
SRPT	SAREPTA THERAPEUTICS INC	$62.78	0.61%	1.65%	1.41%	-44.84%	-49.08%	-52.04%	-14.91%	-44.61%	393.36%	$173.25	$48.01	63.76%	30.76%	0.90	1,357,656	-13.91%
BCRX	BIOCRYST PHARMACEUTICALS INC	$8.71	-1.58%	5.96%	20.14%	14.30%	3.32%	90.59%	-9.27%	146.05%	-6.94%	$9.50	$4.42	8.32%	97.06%	1.17	3,828,838	-20.13%
FOLD	AMICUS THERAPEUTICS INC	$6.68	-13.02%	-7.22%	-15.97%	-30.71%	-41.76%	-35.95%	-4.71%	-40.88%	-36.02%	$12.65	$6.20	47.19%	7.74%	1.02	10,695,703	138.02%
LGND	LIGAND PHARMACEUTICALS INC	$109.15	-0.65%	0.55%	4.13%	-4.89%	-0.81%	52.83%	13.62%	17.37%	36.78%	$129.90	$72.57	15.97%	50.41%	1.10	77,670	-26.57%
TARS	TARSUS PHARMACEUTICALS INC	$50.30	-3.10%	0.66%	2.82%	-7.09%	6.34%	54.82%	259.29%	N/A	N/A	$57.28	$20.08	12.19%	150.47%	0.92	1,057,258	76.72%
ABUS	ARBUTUS BIOPHARMA CORP	$3.61	1.69%	8.08%	3.74%	10.06%	-8.84%	34.20%	47.95%	237.38%	-75.39%	$4.73	$2.70	23.60%	33.70%	0.83	1,002,492	-12.39%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$27.74	2.86%	34.92%	27.42%	46.93%	23.43%	42.99%	194.79%	45.54%	N/A	$28.15	$17.38	1.46%	59.61%	0.95	1,095,180	-26.23%
GLUE	MONTE ROSA THERAPEUTICS INC	$4.90	-0.20%	-6.13%	10.61%	-24.73%	-44.94%	-17.51%	-59.00%	N/A	N/A	$12.40	$3.21	60.48%	52.65%	1.69	286,243	-16.12%
IVVD	INVIVYD INC	$0.61	-3.65%	-9.13%	12.41%	-42.74%	-33.59%	-74.92%	-80.03%	N/A	N/A	$2.74	$0.36	77.85%	70.99%	1.14	513,986	-53.52%
VCEL	VERICEL CORP	$37.92	-0.26%	-7.71%	-11.99%	-35.79%	-13.80%	-19.46%	26.57%	170.66%	1,049.09%	$63.00	$37.39	39.81%	1.42%	1.43	607,304	57.83%
STOK	STOKE THERAPEUTICS INC	$9.87	1.13%	-0.10%	58.43%	-14.32%	-23.25%	-14.62%	-34.16%	-51.28%	N/A	$17.58	$5.35	43.86%	84.49%	1.39	374,793	-34.43%
MDXG	MIMEDX GROUP INC	$6.32	-8.14%	-7.06%	-15.73%	-26.00%	-8.80%	-13.54%	60.00%	N/A	-31.53%	$10.14	$5.47	37.67%	15.54%	1.22	1,510,254	114.40%
CTMX	CYTOMX THERAPEUTICS INC	$0.76	1.75%	-1.17%	30.52%	-9.88%	-27.90%	-85.24%	-58.41%	-93.25%	N/A	$5.06	$0.40	85.04%	89.25%	1.03	712,872	-56.96%
KRYS	KRYSTAL BIOTECH INC	$165.69	-2.47%	-2.03%	-5.09%	4.19%	-6.07%	3.77%	160.31%	257.78%	N/A	$219.34	$141.72	24.46%	16.91%	1.34	257,506	22.07%
ABEO	ABEONA THERAPEUTICS INC	$6.87	4.73%	27.46%	54.38%	24.91%	9.92%	75.70%	27.46%	-87.89%	-90.29%	$7.32	$3.93	6.20%	74.68%	0.77	3,441,373	-81.41%
LEGN	LEGEND BIOTECH CORP	$33.96	-2.83%	-0.82%	7.74%	-8.98%	-23.44%	-22.78%	-19.01%	N/A	N/A	$60.87	$29.27	44.21%	16.04%	0.76	535,207	-50.81%
CORT	CORCEPT THERAPEUTICS INC	$71.48	-0.56%	-0.43%	-22.25%	7.41%	50.10%	199.33%	224.17%	485.90%	1,093.32%	$117.33	$23.02	39.08%	210.51%	0.92	1,031,357	27.32%
TLX	TELIX PHARMACEUTICALS LTD	$17.94	3.10%	-6.66%	7.36%	-2.29%	N/A	N/A	N/A	N/A	N/A	$30.36	$13.61	40.91%	31.81%	0.97	15,595	54.21%
ADMA	ADMA BIOLOGICS INC	$23.27	-2.23%	4.21%	19.82%	41.29%	20.13%	248.88%	1,131.22%	673.09%	180.13%	$25.67	$6.65	9.35%	249.92%	1.06	2,780,813	-1.31%
ONC	BEIGENE LTD	$255.64	-1.61%	-0.20%	-5.68%	14.45%	25.18%	63.32%	53.51%	82.33%	N/A	$287.88	$141.31	11.20%	80.91%	0.94	330,862	-6.29%
XOMA	XOMA ROYALTY CORP	$23.44	-2.50%	-3.26%	21.45%	-5.79%	-22.84%	-9.22%	20.89%	-0.97%	-64.05%	$35.00	$18.35	33.03%	27.72%	0.86	31,698	-7.28%
MGTX	MEIRAGTX HOLDINGS PLC	$7.26	2.40%	10.84%	17.86%	18.43%	24.96%	45.49%	-29.79%	-43.68%	N/A	$8.75	$3.85	17.03%	88.57%	1.21	386,598	25.59%
VCYT	VERACYTE INC	$29.71	-2.59%	-7.56%	0.51%	-34.07%	-13.41%	47.59%	37.61%	13.53%	231.22%	$47.32	$19.73	37.21%	50.58%	1.92	1,276,109	19.15%
GYRE	GYRE THERAPEUTICS INC	$9.34	-4.30%	2.41%	45.71%	-19.27%	-35.45%	-32.61%	31.88%	-88.96%	-99.75%	$19.00	$6.11	50.84%	52.86%	1.13	110,820	31.56%
IMAB	I-MAB	$0.87	-7.13%	2.46%	10.79%	-8.20%	-18.41%	-50.54%	-93.65%	-94.51%	N/A	$2.00	$0.60	56.35%	46.72%	1.10	28,700	-85.29%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$7.36	0.00%	-6.72%	-2.13%	-4.42%	38.61%	163.80%	-15.01%	-75.88%	N/A	$9.01	$2.95	18.31%	149.49%	1.87	2,014,271	1.17%
ENTA	ENANTA PHARMACEUTICALS INC	$6.05	-0.66%	6.70%	13.72%	17.02%	-44.75%	-55.38%	-90.57%	-87.26%	-82.77%	$17.24	$4.09	64.90%	47.92%	0.90	172,257	40.65%
DOMH	DOMINARI HOLDINGS INC	$5.10	11.11%	10.87%	30.77%	50.44%	202.67%	120.11%	-14.94%	-59.07%	-99.49%	$13.58	$0.83	62.44%	517.43%	1.05	394,726	275.68%
ASND	ASCENDIS PHARMA A	$167.47	-1.74%	4.38%	10.59%	33.88%	33.68%	18.76%	83.93%	30.47%	854.25%	$173.00	$111.09	3.20%	50.75%	0.68	927,567	145.53%
VNDA	VANDA PHARMACEUTICALS INC	$4.44	-1.55%	3.02%	-1.33%	3.02%	-4.72%	-6.92%	-56.56%	-60.88%	-53.07%	$6.75	$3.85	34.22%	15.32%	0.73	345,290	7.31%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$25.15	2.95%	-1.37%	9.16%	38.19%	N/A	N/A	N/A	N/A	N/A	$26.50	$17.00	5.09%	47.94%	0.62	6,332	-69.73%
WVE	WAVE LIFE SCIENCES LTD	$7.94	2.85%	16.94%	2.58%	-33.05%	-42.59%	40.04%	326.88%	-4.11%	N/A	$16.74	$4.25	52.55%	86.82%	1.39	2,101,868	0.08%
KURA	KURA ONCOLOGY INC	$6.49	-1.07%	0.93%	1.72%	-21.33%	-61.55%	-68.00%	-56.65%	-53.24%	N/A	$23.48	$5.41	72.36%	19.96%	1.04	1,338,310	38.37%
IBRX	IMMUNITYBIO INC	$2.49	-0.80%	-7.43%	-15.88%	-22.19%	-52.84%	-70.84%	-37.44%	-31.40%	N/A	$10.01	$2.28	75.12%	9.21%	1.97	3,124,440	-9.97%
TVTX	TRAVERE THERAPEUTICS INC	$20.76	-0.24%	17.75%	19.04%	2.67%	18.16%	246.00%	-19.32%	41.51%	-8.99%	$25.29	$6.01	17.91%	245.42%	1.06	1,851,210	22.24%
PTCT	PTC THERAPEUTICS INC	$49.52	-0.64%	-0.06%	6.27%	-0.98%	22.36%	44.96%	36.87%	3.17%	-17.27%	$58.38	$28.72	15.18%	72.42%	0.96	1,135,413	-5.91%
CVAC	CUREVAC NV	$3.40	-4.23%	4.29%	25.00%	-4.23%	23.19%	28.30%	-80.21%	N/A	N/A	$5.28	$2.37	35.61%	43.46%	1.19	399,612	-36.36%
NVAX	NOVAVAX INC	$6.41	-3.90%	-9.34%	6.83%	-23.96%	-31.44%	37.26%	-88.07%	-63.01%	-95.97%	$23.86	$4.43	73.13%	44.70%	1.52	5,448,096	4.01%
MIRM	MIRUM PHARMACEUTICALS INC	$43.42	-0.07%	7.29%	-1.41%	-10.64%	7.48%	68.82%	78.24%	143.66%	N/A	$54.23	$23.83	19.94%	82.21%	0.76	435,167	23.92%
LCTX	LINEAGE CELL THERAPEUTICS INC	$0.50	1.00%	1.20%	22.63%	-26.96%	-38.24%	-55.40%	-58.00%	-38.54%	-90.72%	$1.40	$0.37	64.00%	38.08%	1.02	479,362	-67.85%
NTRB	NUTRIBAND INC	$6.30	-8.43%	18.42%	9.00%	-14.40%	6.24%	80.00%	77.97%	-31.63%	N/A	$11.78	$3.35	46.52%	88.06%	0.50	147,943	-75.96%
KLRS	KALARIS THERAPEUTICS INC	$5.85	-6.70%	-10.28%	-26.88%	-40.31%	-73.32%	-68.60%	-94.41%	N/A	N/A	$24.15	$5.53	75.78%	5.79%	1.46	94,243	279.90%
SPRY	ARS PHARMACEUTICALS INC	$14.16	1.36%	-3.28%	13.01%	15.03%	-7.21%	51.77%	349.52%	N/A	N/A	$18.51	$7.55	23.50%	87.55%	1.02	931,422	-9.18%
FHTX	FOGHORN THERAPEUTICS INC	$4.16	-0.95%	-6.94%	23.26%	4.52%	-49.88%	-29.01%	-65.73%	N/A	N/A	$10.25	$2.95	59.41%	41.26%	1.47	67,787	-41.24%
GOSS	GOSSAMER BIO INC	$1.06	3.92%	8.27%	6.64%	2.91%	21.28%	49.72%	-85.15%	-91.43%	N/A	$1.55	$0.50	31.61%	112.42%	1.36	1,782,964	-45.61%
AKBA	AKEBIA THERAPEUTICS INC	$2.39	-0.83%	4.82%	25.13%	12.74%	41.42%	92.74%	455.81%	-70.05%	-69.55%	$2.89	$0.80	17.30%	198.75%	1.67	2,394,692	-33.08%
ANAB	ANAPTYSBIO INC	$21.70	-2.34%	5.29%	17.93%	30.25%	0.09%	-16.60%	-9.77%	42.02%	N/A	$41.31	$12.21	47.47%	77.72%	0.82	342,150	-41.14%
XLO	XILIO THERAPEUTICS INC	$0.76	-1.44%	-9.90%	10.87%	9.10%	-42.80%	-30.09%	-78.43%	N/A	N/A	$1.70	$0.62	55.59%	21.77%	0.90	108,822	-39.15%
APLS	APELLIS PHARMACEUTICALS INC	$20.08	4.53%	14.48%	-11.46%	-29.52%	-28.23%	-56.40%	-55.34%	-37.29%	N/A	$49.06	$16.98	59.07%	18.29%	1.01	3,791,181	44.33%
CLLS	CELLECTIS SA	$1.61	-1.95%	6.82%	22.20%	3.40%	-10.39%	-36.40%	-54.94%	-86.63%	-95.10%	$3.38	$1.10	52.28%	46.64%	1.45	78,184	74.86%
MESO	MESOBLAST LTD	$11.94	4.74%	0.67%	0.34%	-40.48%	40.80%	65.60%	61.35%	-43.73%	N/A	$22.00	$5.78	45.73%	106.57%	1.27	182,720	96.67%
ZVRA	ZEVRA THERAPEUTICS INC	$7.64	4.23%	5.52%	4.37%	-0.13%	-9.05%	66.09%	66.45%	51.11%	-95.79%	$9.76	$4.20	21.72%	81.90%	0.79	743,293	169.85%
TLSA	TIZIANA LIFE SCIENCES LTD	$1.29	-5.15%	-10.42%	21.70%	90.27%	37.67%	94.86%	26.47%	14.36%	N/A	$1.91	$0.54	32.46%	137.13%	0.76	175,283	-41.17%
BNTX	BIONTECH SE	$102.43	-1.65%	-15.02%	13.45%	-14.51%	-8.12%	13.87%	-29.86%	127.07%	N/A	$131.49	$76.53	22.10%	33.84%	0.95	978,397	12.15%
PULM	PULMATRIX INC	$6.52	-1.30%	-3.63%	6.34%	-13.01%	206.29%	245.19%	23.09%	-76.01%	-99.63%	$10.40	$1.72	37.27%	279.30%	0.53	9,222	63.08%
BNTC	BENITEC BIOPHARMA INC	$14.41	6.03%	3.71%	19.88%	22.12%	31.96%	82.41%	-43.11%	-89.96%	N/A	$16.90	$5.74	14.73%	150.96%	0.68	56,763	-34.81%
NKTR	NEKTAR THERAPEUTICS	$0.78	-1.89%	5.69%	22.45%	-3.58%	-36.59%	-52.73%	-82.67%	-95.68%	-93.21%	$1.93	$0.43	59.54%	80.56%	1.44	1,734,906	-28.17%
UPB	UPSTREAM BIO INC	$9.00	-2.81%	0.45%	34.33%	-9.37%	-63.65%	N/A	N/A	N/A	N/A	$29.46	$5.14	69.45%	75.10%	1.08	267,173	40.85%
CANF	CAN-FITE BIOPHARMA LTD	$1.04	-4.59%	-11.11%	-25.71%	-28.77%	-51.85%	-50.24%	-89.32%	-94.35%	-99.73%	$4.69	$1.03	77.83%	1.46%	0.53	112,231	-49.29%
FBIO	FORTRESS BIOTECH INC	$1.75	-1.13%	5.42%	13.64%	-4.11%	-7.89%	0.57%	-88.56%	-94.28%	-96.15%	$2.89	$1.33	39.45%	32.08%	1.20	102,544	-43.19%
CAPR	CAPRICOR THERAPEUTICS INC	$12.74	0.31%	-4.07%	34.46%	-16.07%	-34.50%	139.02%	266.09%	75.24%	-78.73%	$23.40	$3.52	45.56%	261.93%	0.92	1,295,731	130.32%
RGNX	REGENXBIO INC	$9.83	2.29%	6.85%	45.41%	25.70%	11.83%	-39.32%	-65.44%	-73.04%	N/A	$17.52	$5.04	43.89%	95.23%	1.33	653,870	13.64%
INO	INOVIO PHARMACEUTICALS INC	$1.89	-2.58%	-1.56%	26.00%	-5.03%	-65.32%	-83.69%	-94.71%	-98.47%	-98.13%	$13.44	$1.42	85.94%	33.10%	1.37	777,364	51.50%
MRUS	MERUS NV	$45.45	-0.13%	2.46%	14.77%	14.74%	-9.64%	-3.34%	113.68%	227.92%	N/A	$61.61	$33.19	26.23%	36.94%	0.91	766,212	148.23%
TBPH	THERAVANCE BIOPHARMA INC	$10.39	6.35%	8.91%	15.19%	9.71%	25.48%	17.53%	1.96%	-61.16%	-37.22%	$10.90	$7.44	4.68%	39.65%	0.60	424,569	77.13%
REGN	REGENERON PHARMACEUTICALS INC	$590.00	-1.46%	-1.63%	-4.38%	-11.52%	-30.06%	-34.70%	-9.51%	12.27%	25.22%	$1.21k	$525.99	51.29%	12.17%	0.59	1,189,030	-29.21%
HURA	TUHURA BIOSCIENCES INC	$3.90	3.17%	-7.80%	34.02%	-19.59%	-35.96%	-24.71%	-99.17%	-99.56%	-99.99%	$14.60	$1.80	73.28%	116.67%	0.85	62,971	-53.74%
PTGX	PROTAGONIST THERAPEUTICS INC	$44.99	-1.81%	0.31%	-4.03%	20.94%	-3.79%	76.02%	364.77%	579.61%	N/A	$60.60	$25.23	25.76%	78.32%	1.17	738,771	-14.18%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: B.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 147.93% over the past year, overperforming other biotech stocks by 225 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 400% from Protalix Biotherapeutics's current stock price of $3.00.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 57.69% over the past year, overperforming other biotech stocks by 135 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 59.67% over the past year, overperforming other biotech stocks by 137 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 36.79% from Catalyst Pharmaceuticals's current stock price of $24.27.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.27%, which is 4 percentage points higher than the biotech industry average of 1.81%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.46%, which is 1 percentage points higher than the biotech industry average of 1.81%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.32%, which is the same as the biotech industry average of 1.81%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.68% in the last day, and up 1.97% over the last week. Arvinas was the among the top losers in the biotechnology industry, dropping -24.84% yesterday.

Arvinas shares are trading lower. The company reported Q1 financial results.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -37.78% in the past year. It has overperformed other stocks in the biotech industry by 39 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -1.35% in the past year. It has overperformed other stocks in the biotech industry by 76 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 6.23% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

Are biotech stocks a good buy now?

54.79% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 102% over the next year.

1.74% of biotech stocks have a Zen Rating of A (Strong Buy), 4.13% of biotech stocks are rated B (Buy), 42.39% are rated C (Hold), 35.87% are rated D (Sell), and 15.87% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -169.39x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.